Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

36.52
Delayed Data
As of 4:23pm ET
 -0.12 / -0.33%
Today’s Change
30.90
Today|||52-Week Range
36.88
+12.44%
Year-to-Date
Pfizer's Second Biosimilar of Remicade Receives FDA Approval
4:08pm / Zacks.com - Paid Partner Content
Teva Stock Rises After Announcing Launch of Generic Viagra Competitor
Dec 11 / TheStreet.com - Paid Partner Content
Teva Options Jump to Record Amid New CEO's Latest Bid for Turnaround
2:19pm / TheStreet.com - Paid Partner Content
Pfizer's (PFE) Talazoparib Emerges Superior in EMBRACA Study
Dec 11 / Zacks.com - Paid Partner Content
Novice Trade: Pfizer
Dec 13 / TheStreet.com - Paid Partner Content
Blueprint Medicines and Bluebird Bio Soar on ASH Announcements -- Biotech Movers
Dec 11 / TheStreet.com - Paid Partner Content
Spark Therapeutics Stock Plunges on Hemophilia Therapy Data
Dec 12 / Zacks.com - Paid Partner Content
4 Drug/Biotech Stocks That Could Be Buyout Targets in 2018
Dec 11 / Zacks.com - Paid Partner Content
US Market Indexes Higher on Monday
Dec 12 / GuruFocus News - Paid Partner Content
Why Thousands Will Attend ASH Hematology Conference in Atlanta This Weekend
Dec 08 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close36.64
Today’s open36.70
Day’s range36.35 - 36.88
Volume607,390
Average volume (3 months)16,010,666
Market cap$218.4B
Data as of 4:23pm ET, 12/14/2017

Growth & Valuation

Earnings growth (last year)+5.09%
Earnings growth (this year)+8.12%
Earnings growth (next 5 years)+6.01%
Revenue growth (last year)+8.13%
P/E ratio22.5
Price/Sales3.79
Price/Book3.74

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-0.19-0.22%
MRKMerck-0.42-0.74%
SNYSanofi-0.83-1.89%
ABBVAbbVie-1.05-1.08%
Data as of 4:05pm ET, 12/14/2017

Financials

Next reporting dateJanuary 30, 2018
EPS forecast (this quarter)$0.56
Annual revenue (last year)$52.8B
Annual profit (last year)$7.2B
Net profit margin13.63%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts